Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lacosamide Tablet vs Dry Syrup in Healthy Japanese Men
NCT02972125Phase 1Completed
- Sponsor
- UCB
- Start
- Nov 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lacosamide in epilepsy (2 arms), sponsored by UCB. Primary endpoints: Maximum concentration and Area under the curve from 0 to time of last quantifiable concentration. Started Nov 2016; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02972125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02972125.